Latin America, Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to register a CAGR of 31.0% during the forecast period (2018 - 2024) - KBV Research

12-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, published by KBV research, the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 31.0% CAGR during the forecast period (2018 – 2024).

The Brazil Market held the largest share in the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017. The Argentina market is expected to witness a significant CAGR during the forecast period (2018 – 2024).

The Suprachoroidal Space segment is growing at a significant pace in the Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market during (2018-2024). However, Trabecular Meshwork segment dominated the market in 2017 and is expected to grow at CAGR of 29.4% over the forecast period.

Eye Hospitals among the End Users is dominating the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017 and would retain the same trend by 2024; thereby, growing at a CAGR of 30.5% during (2018-2024). Additionally, Ophthalmology Clinics is growing at significant pace during the forecast period.

Full Report: https://www.kbvresearch.com/lamea-minimally-invasive-glaucoma-surgery-migs-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.

LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

By Surgery